Browse by author
Lookup NU author(s): Tomasz Zaremba, Rafal Zur
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Poly(ADP-ribose) polymerase-1 is a DNA-binding enzyme involved in DNA repair. Poly(ADP-ribose) polymerase inhibitors are a growing class of new agents, currently evaluated in clinical trials (phase 0-2) as standard chemotherapy and radiotherapy sensitizers and non-combinational single agents. Poly(ADP-ribose) polymerase inhibitors have been shown to enhance the antitumor activity of DNA-methylating agents, ionizing radiation, and topoisomerase poisons. They are also emerging as an exciting new treatment for familial breast and ovarian cancers by selective killing of cells with homozygous defects in the breast cancer susceptibility genes, BRCA1 and BRCA2. This paper explains the role of poly(ADP-ribose) polymerase in DNA repair in relation to cancer and discusses published results of preclinical and early clinical studies on poly(ADP-ribose) polymerase inhibitors.
Author(s): Zaremba T, Zur R
Publication type: Article
Publication status: Published
Journal: Cancer and Chemotherapy Reviews
Year: 2009
Volume: 4
Issue: 1
Pages: 27-34
Print publication date: 01/01/2009
ISSN (print): 1885-740X
ISSN (electronic):
Publisher: Permanyer Publications
